Blue Water Life Science Advisors, LP
Follow13F filer, CIK 1789778, LARKSPUR, CA
Blue Water Life Science Advisors, LP reported $126,332,680 across 8 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001420506-25-002029
- Period
- 2025-06-30
- Reported value
- $126M
- Holdings
- 8
- Top 10 weight
- 100%
- New
- 1
- Sold out
- 0
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| TXGnew | +1,100,720 | $12.7M |
| QTRXadded | +585,572 | $3.89M |
| PSNLadded | +500,900 | $3.29M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| GHreduced | -255,000 | -$13.3M |
| NTRAreduced | -42,000 | -$7.1M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q2 2025
Share positions as resolved from 13F-HR 0001420506-25-002029, largest first. % of portfolio is the value over $126,332,680, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| NTRANATERA INC | 166,494 | $28.1M | 22.26% | -42,000 | Timeline | ||
| ADPTADAPTIVE BIOTECHNOLOGIES COR | 2,145,145 | $25M | 19.78% | 0 | Timeline | ||
| GHGUARDANT HEALTH INC | 439,047 | $22.8M | 18.09% | -255,000 | Timeline | ||
| CDNACAREDX INC | 724,014 | $14.1M | 11.2% | 0 | Timeline | ||
| TXG10X GENOMICS INC | 1,100,720 | $12.7M | 10.09% | new | Timeline | ||
| PSNLPERSONALIS INC | 1,676,300 | $11M | 8.7% | +500,900 | Timeline | ||
| QTRXQUANTERIX CORP | 957,747 | $6.37M | 5.04% | +585,572 | Timeline | ||
| AKOYA BIOSCIENCES INC COMAKOYA BIOSCIENCES INC COM | 4,697,785 | $6.11M | 4.83% | 0 |
How Q2 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001420506-25-002029 | base | 2025-08-14 | acceptance time not in the bulk data set |